HemaVista - Crunchbase Company Profile & Funding

Q: When was the last funding round for HemaVista?

HemaVista closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has HemaVista raised to date?

HemaVista has raised obfuscated.

Overview

HemaVista

Total Funding

obfuscation

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About HemaVista

ACHC is a primary care clinic that provides medical, dental, and specialty care for underserved communities.

Closed

Founded

obfuscation

Private

Venture - Series Unknown

Minneapolis, Minnesota, United States

1-10

www.hemavista.com/

Biotechnology

Health Care

Information Technology

Primary and Urgent Care

Supply Chain Management

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Key People

Ben Bowman: Co-Founder and CEO
Dave Mitchell: Co-Founder & EVP

Details

Also Known As

GENERAL BLOOD LLC

Operating Status

Closed

Company Type

For Profit

Founders

Ben Bowman, Dave Mitchell

About the Company

General Blood is the best priced, most reliable partner for FDA licensed blood products delivered through their proven national network. General Blood can immediately save hospitals over 20% on their blood spend and even more over the course of time.

Contact Email

Lisa.gunderson@generalblood.com

Predictions & Insights

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - HemaVista	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - HemaVista	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - HemaVista	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - HemaVista	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - HemaVista	—	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - HemaVista	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - HemaVista	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - HemaVista	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - HemaVista	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - HemaVista	—	obfuscated obfuscation	—	Venture - Series Unknown